Pneumonia in Children under five years old in KPK: Symptoms and presentation
Abstract
Background: The lung parenchyma is affected by pneumonia, an acute infectious disease that can be brought on by fungus, bacteria, or viruses. By vaccination, a healthy diet, and the abolition of environmental variables, pneumonia can be avoided. All worldwide deaths of children under the age of five are due to it. Aim: To prevent pneumonia with easy steps, and can be treated with easy, affordable medications with adequate care, early detection, and prompt admission of sick children to hospitals. Methods: This case series study was carried at pediatric department of district kohat hospital from august 2022 to Feb 2023. Ethical acceptance certificate was obtained from the hospital. Informed written consent was taken from those parents who were willing to answer and were fully qualified the inclusive criteria. Total 139 patients were enrolled in the study. The results were analyzed through spss-ver 24 Results: In clinical sign and symptoms highest ratio was seen in lethargy 33(23.74%) and lowest ratio seen in cyanosis 4 (2.87%), in gender wise the male 82(59%) presentation was more than females 57(41%). Lowest ratio of vaccination was seen in 2(28%) dose 6 and highest in non-vaccination was 21(44%) in dose 1. Conclusion: The health planners should concentrate on the missed epi schedule. Efficacy, we must employ media like radio, television, and newspapers Keywords: Pneumonia, education, health, presentation, Kohat
How strong is the evidence?
Evidence Hub reads this as a case series, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health. Reported size: 139 participants or records.
Read the paper
Related studies
- Penicillins for Treatment of Pneumococcal Pneumonia: Does In Vitro Resistance Really Matter?
- Thiophenes—Naturally Occurring Plant Metabolites: Biological Activities and In Silico Evaluation of Their Potential as Cathepsin D Inhibitors
- Inhalable Mannosylated Rifampicin–Curcumin Co-Loaded Nanomicelles with Enhanced In Vitro Antimicrobial Efficacy for an Optimized Pulmonary Tuberculosis Therapy
- Development and validation of microbial bioassay for quantification of Levofloxacin in pharmaceutical preparations
- GC-MS Analysis and Biomedical Therapy of Oil from n-Hexane Fraction of Scutellaria edelbergii Rech. f.: In Vitro, In Vivo, and In Silico Approach
- Propranolol, chlorpromazine and diclofenac restore susceptibility of extensively drug-resistant (XDR)-Acinetobacter baumannii to fluoroquinolones
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.